Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3033128rdf:typepubmed:Citationlld:pubmed
pubmed-article:3033128lifeskim:mentionsumls-concept:C0206679lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C0020517lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C0003242lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C1704410lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C1534709lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C0205421lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C1707959lld:lifeskim
pubmed-article:3033128lifeskim:mentionsumls-concept:C0301625lld:lifeskim
pubmed-article:3033128pubmed:dateCreated1987-5-26lld:pubmed
pubmed-article:3033128pubmed:abstractTextIntraperitoneal (i.p.) immunization with herpes simplex virus type 1 (HSV-1) or an anti-idiotypic antibody (anti-id C) prepared against a monoclonal antibody specific for glycoprotein C of HSV-1, tolerizes mice for an HSV-1 delayed type hypersensitivity (DTH) response. This tolerization could be adoptively transferred to naive X-irradiated mice by splenic T cells, and was specific for HSV-1 DTH. Thus, DTH-tolerized mice responded to vaccinia virus or HSV-2 challenge, while remaining tolerized for HSV-1 DTH. In addition, these animals demonstrated a form of split tolerance such that HSV antibody, cytotoxic T cell and lymphoproliferative responses were detected in vitro. Thus, anti-id C induced a T cell population capable of specifically suppressing the HSV-1 DTH response, mimicking the effect of i.p. and intravenous immunization with HSV-1 found previously.lld:pubmed
pubmed-article:3033128pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3033128pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3033128pubmed:languageenglld:pubmed
pubmed-article:3033128pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3033128pubmed:citationSubsetIMlld:pubmed
pubmed-article:3033128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3033128pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3033128pubmed:statusMEDLINElld:pubmed
pubmed-article:3033128pubmed:monthAprlld:pubmed
pubmed-article:3033128pubmed:issn0022-1317lld:pubmed
pubmed-article:3033128pubmed:authorpubmed-author:RouseB TBTlld:pubmed
pubmed-article:3033128pubmed:authorpubmed-author:MartinSSlld:pubmed
pubmed-article:3033128pubmed:authorpubmed-author:LatheyJ LJLlld:pubmed
pubmed-article:3033128pubmed:issnTypePrintlld:pubmed
pubmed-article:3033128pubmed:volume68 ( Pt 4)lld:pubmed
pubmed-article:3033128pubmed:ownerNLMlld:pubmed
pubmed-article:3033128pubmed:authorsCompleteYlld:pubmed
pubmed-article:3033128pubmed:pagination1093-102lld:pubmed
pubmed-article:3033128pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:meshHeadingpubmed-meshheading:3033128-...lld:pubmed
pubmed-article:3033128pubmed:year1987lld:pubmed
pubmed-article:3033128pubmed:articleTitleSuppression of delayed type hypersensitivity to herpes simplex virus type 1 following immunization with anti-idiotypic antibody: an example of split tolerance.lld:pubmed
pubmed-article:3033128pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3033128pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3033128lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3033128lld:pubmed